|
US2917432A
(en)
|
1954-10-05 |
1959-12-15 |
Burroughs Wellcome Co |
Leukemia treatment
|
|
US3046301A
(en)
|
1959-10-29 |
1962-07-24 |
Burroughs Wellcome Co |
Method of making chlorambucil
|
|
GB1354939A
(en)
|
1971-10-28 |
1974-06-05 |
Ici Ltd |
Process for the manufacture of 1,1,2-triphenylalk-1-enes
|
|
US4005063A
(en)
|
1973-10-11 |
1977-01-25 |
Abbott Laboratories |
[Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
|
|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
US4282361A
(en)
*
|
1978-03-16 |
1981-08-04 |
Massachusetts Institute Of Technology |
Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
|
|
DE2845574A1
(de)
|
1978-10-19 |
1980-04-24 |
Deutsches Krebsforsch |
Durch heterocyclische ringe oder alkylreste substituierte analoga von ccnu und verfahren zu deren herstellung
|
|
EP0100172B1
(en)
|
1982-07-23 |
1987-08-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US4978672A
(en)
|
1986-03-07 |
1990-12-18 |
Ciba-Geigy Corporation |
Alpha-heterocyclc substituted tolunitriles
|
|
JPS6425763A
(en)
*
|
1987-04-24 |
1989-01-27 |
Mitsubishi Chem Ind |
Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
|
|
US5164196A
(en)
|
1987-05-19 |
1992-11-17 |
Ventech Research, Inc. |
Crotoxin complex as cytotoxic agent
|
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
|
US5002755A
(en)
|
1988-02-18 |
1991-03-26 |
Vanderbilt University |
Method of controlling nephrotoxicity of anti-tumor plaintum compounds
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
AU7885991A
(en)
|
1990-05-26 |
1991-12-31 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
1,4-dihydropyridines for application in combatting resistance to drugs
|
|
FR2665898B1
(fr)
|
1990-08-20 |
1994-03-11 |
Sanofi |
Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
IL100110A0
(en)
|
1990-12-26 |
1992-08-18 |
American Cyanamid Co |
Insecticidal and synergistic miticidal compositions
|
|
CA2119155C
(en)
|
1991-10-18 |
1999-06-15 |
Dennis Paul Phillion |
Fungicides for the control of take-all disease of plants
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
DK0674624T3
(da)
|
1992-12-17 |
1999-09-13 |
Pfizer |
Pyrazoler med CRF-antagonistisk aktivitet
|
|
JP3156026B2
(ja)
|
1993-12-27 |
2001-04-16 |
株式会社大塚製薬工場 |
ホスホン酸ジエステル誘導体
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
WO1996014843A2
(en)
|
1994-11-10 |
1996-05-23 |
Cor Therapeutics, Inc. |
Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
|
|
US5502068A
(en)
|
1995-01-31 |
1996-03-26 |
Synphar Laboratories, Inc. |
Cyclopropylpyrroloindole-oligopeptide anticancer agents
|
|
GB9514380D0
(en)
|
1995-07-13 |
1995-09-13 |
Knoll Ag |
Therapeutic agents
|
|
WO1998004689A1
(en)
|
1995-07-31 |
1998-02-05 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US6218529B1
(en)
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
|
US5675024A
(en)
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
|
JP2000504014A
(ja)
|
1996-01-30 |
2000-04-04 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質転移酵素の阻害剤
|
|
AU706497B2
(en)
|
1996-04-03 |
1999-06-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036897A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036881A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997040017A2
(en)
|
1996-04-19 |
1997-10-30 |
Novo Nordisk A/S |
Modulators of molecules with phosphotyrosine recognition units
|
|
WO1997041824A2
(en)
|
1996-05-03 |
1997-11-13 |
Abbott Laboratories |
Antiangiogenic peptides derived from plasminogen
|
|
JP2000511558A
(ja)
|
1996-06-21 |
2000-09-05 |
アラーガン・セイルズ・インコーポレイテッド |
レチノイドおよび／またはレチノイド拮抗剤様生物学的活性を有する置換テトラヒドロナフタレンおよびジヒドロナフタレン誘導体
|
|
US6268308B1
(en)
|
1996-08-27 |
2001-07-31 |
Syngenta Crop Protection, Inc. |
Herbicidal S-substituted 1,2,4,6-thiatriazines
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
|
CN1246847A
(zh)
|
1996-12-23 |
2000-03-08 |
杜邦药品公司 |
作为Xa因子抑制剂的含氮杂芳族化合物
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
EP0977756A1
(en)
*
|
1997-04-25 |
2000-02-09 |
Pfizer Limited |
PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
|
|
AU7726898A
(en)
*
|
1997-05-22 |
1998-12-11 |
G.D. Searle & Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
|
KR20010013977A
(ko)
|
1997-06-19 |
2001-02-26 |
블레어 큐. 퍼거슨 |
중성 ｐ1 특이성 기를 갖는 인자 ｘａ의 억제제
|
|
NZ503788A
(en)
|
1997-10-27 |
2002-11-26 |
Agouron Pharma |
4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
|
|
EP1040108B1
(en)
|
1997-12-19 |
2004-02-25 |
Schering Aktiengesellschaft |
Ortho-anthranilamide derivatives as anti-coagulants
|
|
IL136637A0
(en)
|
1997-12-22 |
2001-06-14 |
Du Pont Pharm Co |
Nitrogen containing heteroaromatics with ortho-substituted pi's as factor xa inhibitors
|
|
WO1999067235A1
(en)
|
1998-06-25 |
1999-12-29 |
Sumitomo Pharmaceuticals Co., Ltd. |
Five-membered ring compounds
|
|
AU747784B2
(en)
|
1998-07-29 |
2002-05-23 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
|
JP2000186092A
(ja)
|
1998-12-22 |
2000-07-04 |
Kyowa Hakko Kogyo Co Ltd |
Ｕｃｎ−０１の製造法
|
|
WO2000038683A1
(en)
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
|
WO2000059902A2
(en)
|
1999-04-02 |
2000-10-12 |
Du Pont Pharmaceuticals Company |
Aryl sulfonyls as factor xa inhibitors
|
|
PL215901B1
(pl)
|
1999-04-15 |
2014-02-28 |
Bristol Myers Squibb Co |
Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
|
|
US6166244A
(en)
|
1999-05-07 |
2000-12-26 |
Allergan Sales, Inc. |
Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
|
|
EP1185512A2
(en)
|
1999-05-24 |
2002-03-13 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
FR2795726A1
(fr)
|
1999-06-30 |
2001-01-05 |
Aventis Cropscience Sa |
Nouveaux pyrazoles fongicides
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
WO2001014331A2
(en)
|
1999-08-24 |
2001-03-01 |
Regents Of The University Of California |
Non-quinoline inhibitors of malaria parasites
|
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
DE60040676D1
(de)
|
1999-09-17 |
2008-12-11 |
Millennium Pharm Inc |
BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
|
|
JP2003509412A
(ja)
|
1999-09-17 |
2003-03-11 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子阻害剤
|
|
AU1028601A
(en)
|
1999-11-05 |
2001-05-14 |
Smithkline Beecham Plc |
Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
CA2398171C
(en)
|
2000-01-25 |
2016-04-05 |
Vistaprint Usa, Inc. |
Managing print jobs
|
|
HUP0202332A2
(en)
|
2000-02-05 |
2002-10-28 |
Vertex Pharma |
Pyrazole compositions useful as inhibitors of erk
|
|
WO2001058869A2
(en)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
|
|
AU2001250783A1
(en)
|
2000-02-29 |
2001-09-12 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
US20040087798A1
(en)
|
2000-03-14 |
2004-05-06 |
Akira Yamada |
Novel amide compounds
|
|
MY138097A
(en)
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
EP1274705A1
(en)
|
2000-03-29 |
2003-01-15 |
Cyclacel Limited |
2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
|
|
JP2004501083A
(ja)
*
|
2000-04-18 |
2004-01-15 |
アゴーロン・ファーマシューティカルズ・インコーポレイテッド |
プロテインキナーゼを阻害するためのピラゾール
|
|
WO2001081345A1
(en)
|
2000-04-20 |
2001-11-01 |
Mitsubishi Pharma Corporation |
Aromatic amide compounds
|
|
EP1278749B1
(en)
|
2000-04-25 |
2005-01-26 |
Bristol-Myers Squibb Company |
USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
|
|
HK1053833A1
(zh)
|
2000-04-27 |
2003-11-07 |
Abbott Laboratories |
取代苯基法呢基转移酶抑制剂
|
|
US6414013B1
(en)
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
MXPA03000923A
(es)
|
2000-07-31 |
2003-06-09 |
Smithkline Beecham Plc |
Compuestos de carboxamida y su uso como antagonistas de un receptor 11cby humano.
|
|
IL154016A0
(en)
*
|
2000-08-31 |
2003-07-31 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
|
EP1317450B1
(en)
|
2000-09-15 |
2006-11-22 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
CA2420164A1
(en)
|
2000-10-20 |
2002-05-02 |
Bristol-Myers Squibb Pharma Company |
Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
|
|
US6455559B1
(en)
*
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
NZ526472A
(en)
|
2000-12-21 |
2004-04-30 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US6995162B2
(en)
*
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US7105682B2
(en)
*
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
|
EP1372631A4
(en)
|
2001-02-28 |
2005-07-27 |
Brian C Giles |
METHOD AND FORMULA FOR ANTITUMOR AND ANTIMETASTATIC EFFECT
|
|
PL364660A1
(en)
|
2001-03-05 |
2004-12-13 |
E.I.Du Pont De Nemours And Company |
Heterocyclic diamide invertebrate pest control agents
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
EP1372656B1
(en)
*
|
2001-03-16 |
2005-06-22 |
Pfizer Limited |
Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors
|
|
GB0106661D0
(en)
*
|
2001-03-16 |
2001-05-09 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
PL208928B1
(pl)
|
2001-04-16 |
2011-06-30 |
Pharmacopeia |
3, 4-di-podstawione cyklobuten-1, 2-diony jako ligandy receptora CXC chemokiny
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
EP1480597A4
(en)
|
2001-05-11 |
2005-02-02 |
Burnham Inst |
SCREENING, DIAGNOSTIC AND THERAPY PROCEDURES IN CONNECTION WITH RIZ
|
|
WO2002094183A2
(en)
|
2001-05-18 |
2002-11-28 |
Tap Pharmaceutical Products Inc. |
A method for tumor treatment with fumagillol derivatives
|
|
ES2290305T3
(es)
|
2001-05-21 |
2008-02-16 |
E.I. Du Pont De Nemours And Company |
Agentes de control de plagas de invertebrados que contienen un anillo heterociclico no aromatico.
|
|
US20030236198A1
(en)
|
2001-06-13 |
2003-12-25 |
Genesoft, Inc. |
Antipathogenic benzamide compounds
|
|
WO2003011287A1
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazolon derivatives as inhibitors of gsk-3
|
|
ATE491701T1
(de)
|
2001-08-03 |
2011-01-15 |
Vertex Pharma |
Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
|
|
US20030078232A1
(en)
|
2001-08-08 |
2003-04-24 |
Elfatih Elzein |
Adenosine receptor A3 agonists
|
|
AUPR738301A0
(en)
|
2001-08-30 |
2001-09-20 |
Starpharma Limited |
Chemotherapeutic agents
|
|
EP1421077A4
(en)
|
2001-08-31 |
2004-11-17 |
Univ Connecticut |
NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
|
|
EP1429765A2
(en)
|
2001-09-14 |
2004-06-23 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
JP2005505595A
(ja)
|
2001-10-12 |
2005-02-24 |
シェーリング コーポレイション |
Ｃｘｃ−ケモカインレセプターアンタゴニストとしての３，４−二置換マレイミド化合物
|
|
HN2002000317A
(es)
*
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
US6919359B2
(en)
|
2001-11-08 |
2005-07-19 |
Pfizer Inc |
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
ES2251677T3
(es)
|
2002-01-22 |
2006-05-01 |
Warner-Lambert Company Llc |
2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-onas.
|
|
US7205307B2
(en)
|
2002-02-14 |
2007-04-17 |
Icagen, Inc. |
Pyrimidines as novel openers of potassium ion channels
|
|
WO2003075839A2
(en)
|
2002-03-04 |
2003-09-18 |
Aton Pharma, Inc. |
Methods of inducing terminal differentiation
|
|
DE60334781D1
(de)
|
2002-03-12 |
2010-12-16 |
Merck Sharp & Dohme |
Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5
|
|
ATE478872T1
(de)
|
2002-03-28 |
2010-09-15 |
Ustav Ex Botan Av Cr V V I I O |
Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
|
|
US6995168B2
(en)
|
2002-05-31 |
2006-02-07 |
Euro-Celtique S.A. |
Triazaspiro compounds useful for treating or preventing pain
|
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
ATE425753T1
(de)
|
2002-08-02 |
2009-04-15 |
Genesoft Pharmaceuticals Inc |
Biaryl-verbindungen mit antiinfektiver wirkung
|
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
ATE378336T1
(de)
|
2002-09-19 |
2007-11-15 |
Schering Corp |
Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
|
|
US6737382B1
(en)
|
2002-10-23 |
2004-05-18 |
Nippon Soda Co. Ltd. |
Insecticidal aminothiazole derivatives
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
US20050026877A1
(en)
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
CA2851462A1
(en)
|
2003-01-08 |
2004-07-29 |
University Of Washington |
Antibacterial agents
|
|
US7169797B2
(en)
|
2003-02-14 |
2007-01-30 |
Abbott Laboratories |
Protein-tyrosine phosphatase inhibitors and uses thereof
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
|
DK1618092T3
(da)
|
2003-05-01 |
2011-01-31 |
Bristol Myers Squibb Co |
Aryl-substituerede pyrazol-amidforbindelser, der er anvendelige som kinasehæmmere
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
EP1625115A1
(en)
|
2003-05-09 |
2006-02-15 |
Pharmacia & Upjohn Company LLC |
Substituted pyrimidine derivatives
|
|
EP1642594A1
(en)
|
2003-06-27 |
2006-04-05 |
Ono Pharmaceutical Co., Ltd. |
Remedy for urinary tract diseases
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
|
SE0303396D0
(sv)
|
2003-12-16 |
2003-12-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US7875624B2
(en)
|
2004-02-20 |
2011-01-25 |
Novartis Vaccines And Diagnostics, Inc. |
Modulating and measuring cellular adhesion
|
|
HRP20130810T1
(en)
|
2004-03-11 |
2013-09-30 |
4Sc Ag |
Sulphonylpyrroles as hdac inhibitors
|
|
US20060084691A1
(en)
|
2004-10-18 |
2006-04-20 |
Bilal Piperdi |
Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
|
|
AR052559A1
(es)
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
JP5475234B2
(ja)
*
|
2005-01-21 |
2014-04-16 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
KR20070107707A
(ko)
*
|
2005-01-21 |
2007-11-07 |
아스텍스 테라퓨틱스 리미티드 |
피라졸 키나제 억제제와 추가 항종양제의 조합물
|
|
MX2007008781A
(es)
|
2005-01-21 |
2007-09-11 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
|
US20080139620A1
(en)
|
2005-01-21 |
2008-06-12 |
Astex Therapeutics Limited |
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
EP2027109A1
(en)
|
2006-05-05 |
2009-02-25 |
Astex Therapeutics Limited |
4- (2, 6-dichloro-benzoylamino) -1h-pyrazole-s-carboxylic acid (1-methanesulph0nyl-piperidin-4-yl) -amide for the treatment of cancer
|
|
WO2007129062A1
(en)
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
WO2008001101A2
(en)
|
2006-06-29 |
2008-01-03 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
EP2049516A2
(en)
|
2006-07-14 |
2009-04-22 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
WO2008007122A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Combinations of pyrazole derivatives for the inhibition of cdks and gsk's
|
|
EP2049106A2
(en)
|
2006-07-14 |
2009-04-22 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008009954A1
(en)
|
2006-07-21 |
2008-01-24 |
Astex Therapeutics Limited |
Medical use of cyclin dependent kinases inhibitors
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|